These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1732364)

  • 1. Epinephrine infusions during antiarrhythmic drug evaluations: toward a better understanding of drug activity.
    DiMarco JP
    J Am Coll Cardiol; 1992 Feb; 19(2):353-4. PubMed ID: 1732364
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
    Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
    J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of antiarrhythmic drugs based on electrophysiologic studies.
    Prystowsky EN
    Cardiovasc Clin; 1985; 16(1):239-59. PubMed ID: 3837691
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L; Kadish A; Morady F
    Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of supraventricular tachycardia].
    Peters RW
    Recenti Prog Med; 1981 Jul; 71(1):48-68. PubMed ID: 6118917
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
    Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
    J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic body surface mapping in patients with ventricular tachycardia. Assessment of utility in the identification of effective pharmacological therapy.
    Mitchell LB; Hubley-Kozey CL; Smith ER; Wyse DG; Duff HJ; Gillis AM; Horacek BM
    Circulation; 1992 Aug; 86(2):383-93. PubMed ID: 1638707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 10. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of supraventricular arrhythmias.
    Donaldson RM
    Br J Hosp Med; 1979 Apr; 21(4):344, 348, 353-4. PubMed ID: 35261
    [No Abstract]   [Full Text] [Related]  

  • 12. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
    Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 14. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
    Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S
    Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy.
    Wren C; Campbell RW
    Eur Heart J; 1987 Jun; 8(6):647-50. PubMed ID: 3113958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
    Kim SG; Felder SD; Figura I; Johnston DR; Mercando AD; Fisher JD
    Am J Cardiol; 1987 Jun; 59(15):1314-8. PubMed ID: 3591686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.